Skip to main content

Serina Therapeutics, Inc.

SER
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001708599

In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.

Superinvestors holding SER, Q2 2026

See all superinvestors

No superinvestor reported holding SER in Q2 2026.